As South Korea's doctors continue their long-running protest against a government plan to raise the medical student quota at universities, the walk-outs may be beginning to take a toll on the pharma industry, with many large firms reporting weak earnings in the last quarter.
The South Korean pharma industry is beginning to feel the fallout from the prolonged national walkout by trainee doctors that began in February.
Although the overall impact from the medical strike appears to be limited so far, sales of drugs related to surgeries...